nipoka.com

What It Is

NIPOKA’s PEMP (Podocyte Exact Morphology Measurement Procedure) is not a general-purpose enterprise SaaS product, but a specialized podocyte morphology quantification workflow for nephrology research. It is used to measure podocyte foot process morphology and slit diaphragm density, and is suitable for analyzing biopsy samples as well as mouse and rat kidney tissue sections. The page clearly states that PEMP is currently for research use only.

Core Features

PEMP’s main value lies in converting podocyte morphology into a single, objective, comparable quantitative value, helping researchers identify subtle morphological changes. Its analysis can cover 20 or more glomeruli per section, strengthening the basis for statistical inference. It also supports biomarker staining such as WT1 and Synaptopodin; the page mentions that up to 4 biomarkers can be used per section, and users may choose existing markers or send in their preferred markers. In addition, PEMP supports 3D podocyte morphology reconstruction with depth color coding and provides representative high-resolution images.

Pricing and Trial

The website does not disclose formal commercial plans, subscription fees, or per-analysis pricing. What is clearly offered is a free trial analysis: after users send fixed tissue, paraffin blocks, or standard FFPE sections, they can receive PEMP analysis of 20 glomeruli, the necessary preprocessing steps, and representative high-resolution images, with no commitment and no cost.

Pros and Cons

Its strengths are its highly focused research use case, objective quantitative outputs, and methodological backing from multiple peer-reviewed papers. It can be valuable for research teams that need to compare the degree of podocyte injury. The limitations are also clear: unlike a standard SaaS product, it does not disclose information about account systems, permissions, APIs, cloud deployment, or security and compliance; the workflow depends on sample shipment and expert analysis, and the level of automated self-service is unclear; and it is limited to research use, so it should not be treated directly as a clinical diagnostic tool.

Who It’s For and Access from China

PEMP is better suited to nephrology, pathology, histology, and animal model research teams, especially laboratories that need quantitative analysis of podocyte foot process injury and publication-grade imaging results. The page does not provide information on access from China, and payment methods are not disclosed. Since the service involves cross-border shipment of biological samples, teams in China will also need to further assess logistics, ethics approval, customs requirements, and sample compliance. Possible alternatives include local pathology image analysis platforms, microscopy image quantification software, or collaborating with domestic nephrology laboratories to develop an analysis workflow.